Literature DB >> 20829814

India's Cipla sets sights on Avastin, Herceptin and Enbrel.

Killugudi Jayaraman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20829814     DOI： 10.1038/nbt0910-883a

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  Regulatory frameworks in developing countries.

Authors:  Colin Longstaff; Craig Thelwell; Colin Whitton
Journal:  Nat Biotechnol       Date:  2005-04       Impact factor: 54.908

2.  Pharma swept up in biogenerics gold rush.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2009-04       Impact factor: 54.908
  2 in total
  2 in total

Review 1.  Biosimilar drugs: Current status.

Authors:  Rajiv Kumar; Jagjit Singh
Journal:  Int J Appl Basic Med Res       Date:  2014-07

2.  Leprosy detection rate in patients under immunosuppression for the treatment of dermatological, rheumatological, and gastroenterological diseases: a systematic review of the literature and meta-analysis.

Authors:  Daniel Holanda Barroso; Jurema Guerrieri Brandão; Elaine Silva Nascimento Andrade; Ana Clara Banhatto Correia; Danielle Costa Aquino; Ana Carolina Rios Chen; Sebastian Vernal; Wildo Navegantes de Araújo; Lícia Maria Henrique da Mota; Raimunda Nonata Ribeiro Sampaio; Patrícia Shu Kurizky; Ciro Martins Gomes
Journal:  BMC Infect Dis       Date:  2021-04-13       Impact factor: 3.090
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.